Bharat Biotech Co-Founder and Joint MD Suchitra Ella on Tuesday said that Covaxin has reached thirty cities in thirty days despite some employees being off work due to COVID.
"COVAXIN reaches 30 cities within 30 day. All our employees are committed, working 24x7 thru lockdowns for the country's immunisation - pls send your prayers to their families, some are still quarantined & off work," Ella said in a tweet.
By way of dispatch to private hospitals, the vaccine has reached various cities, including Amritsar, Bangalore, Chennai, Delhi, Ernakulam, Jaipur, Hyderabad, Kanpur, Kolkata, Guwahati, Mysore, Pune, Raipur, Mohali and Vijayawada.
Last week, Bharat Biotech said it plans to produce additional 200 million (20 crore) doses of Covaxin at its subsidiary's facility in Gujarat. This will take the overall production volume of the vaccine to about 1 billion (100 crore) doses per annum.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)